VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹55 Cr | ₹65 Cr | ₹62 Cr | ₹50 Cr | ₹58 Cr |
What is the latest Short Term Loans and Advances ratio of VENUS REMEDIES ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹55 Cr |
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹58 Cr |
How is Short Term Loans and Advances of VENUS REMEDIES Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹55 Cr | -16.20 | |
| Mar2025 | ₹65 Cr | 5.81 | |
| Mar2024 | ₹62 Cr | 24.08 | |
| Mar2023 | ₹50 Cr | -14.58 | |
| Mar2022 | ₹58 Cr | - | |
Compare Short Term Loans and Advances of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,027.2 Cr | -4.7% | -4.9% | 251.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.7% |
-4.9% |
251.5% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses